Literature DB >> 21152798

Exogenous ochronosis hydroquinone induced: a report of four cases.

Jonas Ribas1, Antonio Pedro Mendes Schettini, Melissa de Sousa Melo Cavalcante.   

Abstract

Exogenous ochronosis is an infrequent dermatosis characterized as a dark blue hyperpigmentation localized where the causing agent was applied. It may be caused by the use of systemic medication such as antimalarials and by the use of topic substances such as phenol, resorcinol, benzene, or hydroquinone, which is a fenolic compound with depigmentation action, largely used in the treatment of melasma and other hyperpigmentation. The physiopathology of this process is not well clear up to this moment, and the therapeutic measures are not satisfactory either. Here we present four cases of female patients that developed hyperpigmentation on their faces after the use of hydroquinone containing compounds, characterized clinically and histological as ochronosi. We emphasize the possibility of exogenous ochronosis cases being misdiagnosed as a melasma treatment failure. We also emphasize the risks of the indiscriminated use of hydroquinone containing compounds, used, in many instances, without medical prescription.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21152798     DOI: 10.1590/s0365-05962010000500017

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  3 in total

1.  [Progressive facial hyperpigmentation].

Authors:  A Blumeyer; J Röwert-Huber; A Nast; U Reidel
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

2.  Adverse cutaneous reactions to skin care products on the face vary with age, but not with sex.

Authors:  Li-Ning Huang; Yi-Ping Zhong; Dan Liu; Xiao-Hua Wang; Can-Yi Gong; Si Wen; Peter M Elias; Bin Yang; Mao-Qiang Man
Journal:  Contact Dermatitis       Date:  2018-09-12       Impact factor: 6.600

3.  Evidence-based treatment for melasma: expert opinion and a review.

Authors:  Krupa Shankar; Kiran Godse; Sanjeev Aurangabadkar; Koushik Lahiri; Venkat Mysore; Anil Ganjoo; Maya Vedamurty; Malavika Kohli; Jaishree Sharad; Ganesh Kadhe; Pashmina Ahirrao; Varsha Narayanan; Salman Abdulrehman Motlekar
Journal:  Dermatol Ther (Heidelb)       Date:  2014-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.